Control of histone H3 phosphorylation by CaMKII. in response to haemodynamic cardiac stress

Journal of Pathology

Volumn 235, Issue 4, 2015, Pages 606-618

  Awad, Salma ^a   Al Haffar, Kamar Mohamed Adib ^a   Marashly, Qussay ^b   Quijada, Pearl ^c   Kunhi, Muhammad ^a   Al Yacoub, Nadya ^a   Wade, Fallou S ^a   Mohammed, Shamayel Faheem ^a   Al Dayel, Fouad ^a   Sutherland, George ^a   Assiri, Abdullah ^a   Sussman, Mark ^c   Bers, Donald ^d   Al Habeeb, Waleed ^e   Poizat, Coralie ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

14 3 3; CaMKII ; Cardiac hypertrophy; Epigenetic; H3 phosphorylation; Transcription

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IIDELTA; HISTONE H3; MYOCYTE ENHANCER FACTOR 2; PROTEIN 14 3 3; RNA POLYMERASE II; SERINE; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG; CAMK2D PROTEIN, HUMAN; CAMK2D PROTEIN, MOUSE; CAMK2D PROTEIN, RAT; HISTONE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; GENE EXPRESSION; HEART FAILURE; HEART HEMODYNAMICS; HEART HYPERTROPHY; HEART MUSCLE; HEART MUSCLE CELL; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; HEMODYNAMIC STRESS; HISTONE PHOSPHORYLATION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RAT; TRANSCRIPTION ELONGATION; UPREGULATION; ANIMAL; BINDING SITE; CARDIAC MUSCLE CELL; CARDIOMEGALY; CELL CULTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HEMODYNAMICS; MALE; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; RNA INTERFERENCE;

14-3-3 PROTEINS; ANIMALS; BINDING SITES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CARDIOMEGALY; CELLS, CULTURED; CHROMATIN ASSEMBLY AND DISASSEMBLY; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART FAILURE; HEMODYNAMICS; HISTONES; HUMANS; MALE; MICE, KNOCKOUT; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RNA INTERFERENCE; RNA POLYMERASE II; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84922759580     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4489     Document Type: Article

References (45)

1. Kornberg RD, Lorch Y. Twenty-fve years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 1999; 98: 285-294.
2. Zentner GE, Henikoff S. Regulation of nucleosome dynamics by histone modifcations. Nat Struct Mol Biol 2013; 20: 259-266.
3. Chang CP, Bruneau BG. Epigenetics and cardiovascular development. Annu Rev Physiol 2012; 74: 41-68.
4. Mahmoud SA, Poizat C. Epigenetics and chromatin remodeling in adult cardiomyopathy. J Pathol 2013; 231: 147-157.
5. Cheung P, Allis CD, Sassone-Corsi P. Signaling to chromatin through histone modifcations. Cell 2000; 103: 263-271.
6. Bode AM, Dong Z. Inducible covalent posttranslational modifcation of histone H3. Sci STKE 2005; 2005: re4.
7. Mahadevan LC, Willis AC, Barratt MJ. Rapid histone H3 phospho-rylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell 1991; 65: 775-783.
8. Thomson S, Clayton AL, Hazzalin CA, et al. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J 1999; 18: 4779-4793.
9. Sassone-Corsi P, Mizzen CA, Cheung P, et al. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 1999; 285: 886-891.
10. Yamamoto Y, Verma UN, Prajapati S, et al. Histone H3 phosphoryla-tion by IKKα is critical for cytokine-induced gene expression. Nature 2003; 423: 655-659.
11. Porrello ER, Mahmoud AI, Simpson E, et al. Transient regenerative potential of the neonatal mouse heart. Science 2011; 331: 1078-1080.
12. Mollova M, Bersell K, Walsh S, et al. Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci USA 2013; 110: 1446-1451.
13. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998; 83: 1-14.
14. Liew CC, Sole MJ. Studies of nuclear proteins in the heart of the cardiomyopathic Syrian hamster-phosphorylation of histones. J Mol Cell Cardiol 1978; 10: 847-855.
15. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006; 7: 589-600.
16. Abraham WT, Gilbert EM, Lowes BD, et al. Coordinate changes in myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med 2002; 8: 750-760.
17. Meyer K, Lubo Z. Fetal programming of cardiac function and disease. Reprod Sci 2007; 14: 209-216.
18. Hang CT, Yang J, Han P, et al. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 2010; 466: 62-67.
19. 2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res 2004; 63: 476-486.
20. Backs J, Backs T, Neef S, et al. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci USA 2009; 106: 2342-2347.
21. Swaminathan PD, Purohit A, Hund TJ, et al. Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ Res 2012; 110: 1661-1677.
22. Erickson JR, Pereira L, Wang L, et al. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 2013; 502: 372-376.
23. Backs J, Song K, Bezprozvannaya S, et al. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 2006: 1-12.
24. Little GH, Bai Y, Williams T, et al. Nuclear calcium/calmodulin-dependent protein kinase IIδ preferentially transmits signals to histone deacetylase 4 in cardiac cells. J Biol Chem 2007; 282: 7219-7231.
25. Awad S, Kunhi M, Little GH, et al. Nuclear CaMKII enhances histone H3 phosphorylation and remodels chromatin during cardiac hypertrophy. Nucleic Acids Res 2013; 41: 7656-7672.
26. Izumo S, Nadal-Ginard B, Mahdavi V. Proto-oncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 1988; 85: 339-343.
27. Goto H, Tomono Y, Ajiro K, et al. Identifcation of a novel phos-phorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem 1999; 274: 25543-25549.
28. Macdonald N, Welburn JP, Noble ME, et al. Molecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 14-3-3. Mol Cell 2005; 20: 199-211.
29. Walter W, Clynes D, Tang Y, et al. 14-3-3 interaction with histone H3 involves a dual modifcation pattern of phosphoacetylation. Mol Cell Biol 2008; 28: 2840-2849.
30. Karam CS, Kellner WA, Takenaka N, et al. 14-3-3 mediates histone cross-talk during transcription elongation in Drosophila. PLoS Genet 2010; 6: e1000975.
31. 2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 2009; 119: 1230-1240.
32. Anderson ME, Brown JH, Bers DM. CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 2011; 51: 468-473.
33. Little GH, Saw A, Bai Y, et al. Critical role of nuclear calcium/calmodulin-dependent protein kinase IIδB in cardiomy-ocyte survival in cardiomyopathy. J Biol Chem 2009; 284: 24857-24868.
34. Peng W, Zhang Y, Zheng M, et al. Cardioprotection by CaMKII-δB is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70. Circ Res 2010; 106: 102-110.
35. Xin M, Kim Y, Sutherland LB, et al. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci Signal 2011; 4: ra70.
36. von Gise A, Lin Z, Schlegelmilch K, et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci USA 2012; 109: 2394-2399.
37. Xin M, Kim Y, Sutherland LB, et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci USA 2013; 110: 13839-13844.
38. Mahmoud AI, Kocabas F, Muralidhar SA, et al. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 2013; 497: 249-253.
39. Nadal-Ginard B, Kajstura J, Leri A, et al. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 2003; 92: 139-150.
40. Lopez JE, Myagmar BE, Swigart PM, et al. β-Myosin heavy chain is induced by pressure overload in a minor subpopulation of smaller mouse cardiac myocytes. Circ Res 2011; 109: 629-638.
41. Ivaldi MS, Karam CS, Corces VG. Phosphorylation of histone H3 at Ser10 facilitates RNA polymerase II release from promoter-proximal pausing in Drosophila. Genes Dev 2007; 21: 2818-2831.
42. Vega RB, Matsuda K, Oh J, et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004; 119: 555-566.
43. Baek SH. When signaling kinases meet histones and histone modi-fers in the nucleus. Mol Cell 2011; 42: 274-284.
44. Lo WS, Trievel RC, Rojas JR, et al. Phosphorylation of ser-ine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol Cell 2000; 5: 917-926.
45. Hohl M, Wagner M, Reil JC, et al. HDAC4 controls histone methy-lation in response to elevated cardiac load. J Clin Invest 2013; 123: 1359-1370.